Katalog der Deutschen Nationalbibliothek

Neuigkeiten Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00
 
Neuigkeiten Dienstag 9. Dezember 2025: Die Lesesäle der Deutschen Nationalbibliothek in Leipzig öffnen wegen einer Personalversammlung erst ab 13 Uhr. // Tuesday 9 December 2025: The reading rooms of the German National Library in Leipzig will open at 13:00 due to a staff assembly.
 
 
 


Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

91 - 100 von 117
<< < > >>


Artikel 91 Evaluating the impact of the single exit price policy on a basket of originator medicines in South Africa from 1999 to 2014 using a time series analysis
Enthalten in BMC health services research Bd. 19, 16.8.2019, Nr. 1, date:12.2019: 1-13 		Online Ressource
Artikel 92 Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database
Enthalten in Journal of pharmaceutical health care and sciences Bd. 5, 7.10.2019, Nr. 1, date:12.2019: 1-4 		Online Ressource
Artikel 93 Forced Degradation Products of Liraglutide: A Comparative Study of Similarity Between Originator and Analogue Version by Liquid Chromatography–Mass Spectrometry
Enthalten in International journal of peptide research and therapeutics Bd. 30, 24.4.2024, Nr. 3, date:5.2024: 1-13 		Online Ressource
Artikel 94 Forty-Eight-Month Monitoring of Disease Activity in Patients with Long-Standing Rheumatoid Arthritis Treated with TNF-α Inhibitors: Time for Clinical Outcome Prediction and Biosimilar vs Biologic Originator Performance
Enthalten in Clinical drug investigation Bd. 44, 31.1.2024, Nr. 3, date:3.2024: 141-148 		Online Ressource
Artikel 95 Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Aspart (MYL-1601D) Compared with Originator Insulin Aspart (Novolog®) in Patients with Type 1 Diabetes After 24 Weeks: A Randomized Open-Label Study
Enthalten in BioDrugs Bd. 36, 17.9.2022, Nr. 6, date:11.2022: 761-772 		Online Ressource
Artikel 96 Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis
Enthalten in BioDrugs Bd. 37, 23.3.2023, Nr. 3, date:5.2023: 409-420 		Online Ressource
Artikel 97 Impact of switching from the originator adalimumab to a biosimilar: a retrospective cohort study
Enthalten in BMC immunology Bd. 26, 3.7.2025, Nr. 1, date:12.2025: 1-13 		Online Ressource
Artikel 98 In Vitro Biological Characterization of Recombinant Insulin Aspart from Biogenomics and Originator Insulin Aspart
Enthalten in BioDrugs Bd. 37, 7.6.2023, Nr. 5, date:9.2023: 709-719 		Online Ressource
Artikel 99 Incidence of and Reasons and Determinants Associated with Retransitioning from Biosimilar Etanercept to Originator Etanercept
Enthalten in BioDrugs Bd. 35, 26.10.2021, Nr. 6, date:11.2021: 765-772 		Online Ressource
Artikel 100 Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience
Enthalten in Internal and emergency medicine Bd. 18, 24.2.2023, Nr. 3, date:4.2023: 791-799 		Online Ressource


91 - 100 von 117
<< < > >>




Materialarten

Alle Materialarten > Artikel (117)

Standorte

Alle Standorte > Leipzig (117)

Aktionen

Aktionen


E-Mail-IconAdministration